Active pulmonary Koch’s in a locally advanced recurrent head and neck malignancy: a case report
Keywords:Koch's, Palliative care, Head and neck cancer
Even though the global incidence of tuberculosis (TB) has been showing a declining trend every year, it is still a significant public health problem in India. On the other hand, cancer has also been the reason for considerable mortality and morbidity across this population. The incidence of TB has been reportedly increasing in patients with both pulmonary and non-pulmonary cancers. Incidence of pulmonary TB in head and neck malignancy is around 3.1% to 6.6%. We present a case history of 50 years old with locally advanced recurrent head and neck malignancy with active pulmonary Koch’s. The decision was to provide him supportive care and treating the infection was pragmatic in spite of expected delay in anti-cancer treatment. It is extremely important to come up with a proper protocol for the need of prophylactic treatment, detection and the concurrent treatment of both cancer and TB.
Chakraborty AK. Epidemiology of tuberculosis: current status in India. Indian J Med Res. 2004;120(4):248-76.
Mathur P, Sathishkumar K, Chaturvedi M, Das P, Sudarshan KL, Santhappan S, et al. Cancer Statistics, 2020: Report From National Cancer Registry Programme, India. JCO Glob Oncol. 2020;6:1063-75.
Cakar B, Ciledag A. Evaluation of coexistence of cancer and active tuberculosis; 16 case series. Respir Med Case Rep. 2017;23:33-7.
Libshitz HI, Pannu HK, Elting LS, Cooksley CD. Tuberculosis in cancer patients: an update. J Thorac Imaging. 1997;12(1):41-6.
Abul Y, Eryuksel E, Balci M, Yumuk F, Karakurt S, Ceyhan B. Cancer and tuberculosis: case series. J BUON. 2010;15(2):392-4.
Paiva D, Curioni OA, Souza RP, Vianna D, França LJ, Sobreiro LE, et al. Prevalence of alterations in chest computerized tomography in patients with head and neck cancer. Rev Col Bras Cir. 2015;42(6):356-9.
Papac RJ. Medical aspects of head and neck cancer. Cancer Invest. 1985;3(5):435-44.
Cheng MP, Abou CCN, Yansouni CP, Cnossen S, Shrier I, Menzies D, et al. Risk of Active Tuberculosis in Patients with Cancer: A Systematic Review and Meta-Analysis. Clin Infect Dis. 2017;64(5):635-44.
Lai SW, Lin CL, Liao KF. Head and neck cancer associated with increased rate of pulmonary tuberculosis in a population-based cohort study. Medicine. 2017;96(43):8366.
Shu CC, Liao KM, Chen YC, Wang JJ, Ho CH. The burdens of tuberculosis on patients with malignancy: incidence, mortality and relapse. Sci Rep. 2019;9(1):11901.
Ganzel C, Silverman B, Chemtob D, Shoham A, Well Y. The risk of tuberculosis in cancer patients is greatest in lymphoma and myelodysplastic syndrome/myeloproliferative neoplasm: a large population-based cohort study. Leuk Lymphoma. 2019;60(3):720-5.
Fan WC, Ting WY, Lee MC, Huang SF, Chiu CH, Lai SL, et al. Latent TB infection in newly diagnosed lung cancer patients - A multicenter prospective observational study. Lung Cancer. 2014;85(3):472-8.
Harris BN, Pipkorn P, Nguyen KNB, Jackson RS, Rao S, Moore MG, et al. Association of Adjuvant Radiation Therapy With Survival in Patients With Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck. JAMA Otolaryngol Head Neck Surg. 2019;145(2):153-8.
Bailey W, Albert R, Davidson P, Farer L, Glassroth J, Kendig EJ. Treatment of tuberculosis and other mycobacterial diseases. Am Rev Respir Dis. 1983;127(6):790-6.
Matsuo M. Development of active tuberculosis during treatment of head and neck carcinoma: a case series. J Med Case Rep. 2019;13(1):162.
Muscaritoli M, Lucia S, Farcomeni A, Lorusso V, Saracino V, Barone C, et al. Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study. Oncotarget. 2017;8(45):79884-96.
Safdar A, Armstrong D. Infectious morbidity in critically ill patients with cancer. Crit Care Clin. 2001;17(3):531-70.
Rolston KV. Infections in Cancer Patients with Solid Tumors: A Review. Infect Dis Ther. 2017;6(1):69-83.